Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravenous Continuous LMWH (Enoxaparin) Seems to be Safe Alternative to UFH in Patients With VV ECMO

NCT06010446 is registered in ClinicalTrials.gov with University Hospital, Motol as lead sponsor.

NCT NCT06010446
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06010446 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravenous Continuous LMWH (Enoxaparin) Seems to be Safe Alternative to UFH in Patients With VV ECMO
Lead sponsor
University Hospital, Motol
Phase
Observational
Overall status
Completed
Start date
May 15, 2019
Completion date
August 15, 2023
Enrollment
43 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

refractory respiratory failure